Valeant Pharmaceuticals International, Inc. 4

4 · Valeant Pharmaceuticals International, Inc. · Filed Aug 14, 2013

Form 4

Period: 2013-08-12

EVO, Co. Grp. Chmn, Eye Health

Transactions

Award
Restricted Share Units
2013-08-12+31,600→ 31,600 total
Exercise: $0.00→ Common Shares, no par value (31,600 underlying)
Award
Non-Qualified Stock
2013-08-12+82,000→ 82,000 total
Exercise: $101.87From: 2017-08-12Exp: 2023-08-12→ Common Shares, no par value (82,000 underlying)

Footnotes (3)

[F1]Each Restricted Share Unit ("RSUs") represents a contingent right to receive between zero and three common shares, no par value, of Valeant Pharmaceuticals International, Inc. ("Valeant"), subject to performance based vesting criteria. See note (2).
[F2]The performance based RSUs are eligible to vest on the achievement of TSR targets ranging from 10% to 30% over a base price of $93.84 each of three measurement dates: 25% would vest on May 12, 2016, 50% on August 12, 2016 and 25% on November 12, 2016, with early vesting possible at higher TSR levels.
[F3]The options vest 25% per year for 4 years starting from the date of grant with the first vest date falling on the first anniversary of the grant, the second vest date falling on the second anniversary of the grant, the third vest date falling on the third anniversary of the grant and the fourth vest date falling on the fourth anniversary of the grant.

Documents

2 files